Our study unveils, for the first time, the upregulation of ANRIL in the lung tissues of mice treated with BLM, leading to the enhancement of fibroblast proliferation and differentiation, exacerbating pulmonary fibrosis. The gene discussed is CDKN2B-AS1; the disease is pulmonary fibrosis.